FDA Clearance Tracker · K190795
Tetragraph Neuromuscular Transmission Monitor
Last checked: Nov 20, 2026Latest source record: Oct 18, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 18, 2019
Substantially Equivalent
Time to decision
204 days
Received Mar 28, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K190795
- Device name
- Tetragraph Neuromuscular Transmission Monitor
- Applicant
- Senzime AB
- Applicant location
- Uppsala, SE
- Received
- Mar 28, 2019
- Decided
- Oct 18, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 868.2775
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KOI. The earliest in FDA's data is K840108, decided Feb 17, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K190795
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Senzime AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261098 · Decided May 22, 2026 · 50 days after receipt
Device type: Stimulator, Nerve, Peripheral, Electric (KOI) · Anesthesiology & Respiratory
K220530 · Decided Aug 17, 2022 · 174 days after receipt
Device type: Stimulator, Nerve, Peripheral, Electric (KOI) · Anesthesiology & Respiratory
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.